Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
108 studies found for:    "Bacterial Infections" | Canada
Show Display Options
Rank Status Study
1 Completed
Has Results
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
Conditions: Streptococcal Infection;   Gram-positive Bacterial Infection;   Bacterial Infection
Interventions: Biological: Group B Streptococcus Trivalent Vaccine;   Biological: Placebo
2 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
3 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
4 Recruiting Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Conditions: Acute Leukemias of Ambiguous Lineage;   Bacterial Infection;   Diarrhea;   Fungal Infection;   Musculoskeletal Complications;   Neutropenia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Intervention: Drug: levofloxacin
5 Completed
Has Results
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA;   Drug: Linezolid
6 Completed A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Wound Infection;   Cutaneous Abscess;   Burn Infection;   Cellulitis
Intervention: Drug: AFN-12520000
7 Unknown  Study of Complication Rates Associated With PICC for Left vs Right
Condition: Bacterial Infections
Interventions: Procedure: Placement of PICC in right arm;   Procedure: PICC placement in Left arm
8 Completed What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
Conditions: Bacterial Infections;   Gram-Positive Bacterial Infections;   Staphylococcal Infections
Intervention:
9 Completed Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source
Conditions: Procalcitonin;   Fever Without Source;   Bacterial Infection;   Bacteremia
Intervention: Other: Procalcitonin dosage PCT-Q test (Brahms, Germany)
10 Completed Hospital Wide Roll-Out of Antimicrobial Stewardship
Condition: Bacterial Infections
Intervention: Other: Antibiotic stewardship audit-and-feedback to prescribers of patients receiving 3rd or 10th day of targeted broadspectrum antibiotics
11 Completed Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
Conditions: Impetigo;   Skin Infections, Bacterial
Intervention: Drug: SB-275833 ointment, 1%
12 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
13 Completed
Has Results
An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia
Conditions: Pneumonia;   Bacterial Pneumonia;   Ventilator-Associated Pneumonia;   Infections, Nosocomial
Intervention: Drug: doripenem
14 Completed
Has Results
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
15 Completed Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Intervention: Biological: Serogroup B meningococcal vaccine
16 Completed
Has Results
Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Tetanus-diphtheria-acellular pertussis (Tdap) vaccine
17 Completed A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea
Conditions: Clostridium Enterocolitis;   Pseudomembranous Colitis
Intervention: Drug: tolevamer potassium-sodium (GT267-004)
18 Completed
Has Results
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
Condition: Meningococcal Infections
Interventions: Biological: MenACWY-CRM;   Biological: Licensed meningococcal ACWY vaccine
19 Completed
Has Results
Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Conditions: Clostridium Infections;   Diarrhea
Interventions: Drug: fidaxomicin;   Drug: Vancomycin
20 Completed Early Versus Delayed Pneumococcal Vaccination in HIV
Condition: Pneumococcal Infections
Interventions: Biological: Pneumovax;   Biological: Prevnar

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years